Scholars Central

EditorialPublished 4 Jun 2021

Hematopoietic Somatic Cell Transplantation Application

Authors: Hui-Yua Tsai

Japan School of Medicine and Medical Sciences, Japan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Stem cell transplantation has been wont to cure thousands of individuals WHO have cancer; however there are unit serious risks to the current treatment. Before undergoing somatic cell transplantation, patients considering this treatment ought to discuss the risks and advantages with their doctors. The risks of somatic cell transplantation have attenuated with the passing of every decade. In progress analysis is probably going to still improve the procedure. For a few diseases and patients, however, effective new medication and new styles of therapies could also be higher treatment choices than somatic cell transplantation. Doctors and their patients can take into account several factors once deciding whether or not somatic cell transplantation is that the best treatment possibility.

Subjects

Surgery

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Clinical and Experimental Transplantation.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Experimental Transplantation
  • SubjectSurgery
  • BylineArticles whose byline prints “Hui-Yua Tsai”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels